(Q34533774)

2 August 2017

Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases (English)

1 reference

2 August 2017

Inhibitory effects of ketotifen on eotaxin‐dependent activation of eosinophils: consequences for allergic eye diseases (English)

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

3 January 2024

author name string

G. Woerly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752326

3 January 2024

S. Loiseau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752326

3 January 2024

M. Loyens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752326

3 January 2024

C. Schoch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752326

3 January 2024

M. Capron

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752326

3 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12752326

3 January 2024

publication date

1 May 2003

1 reference

full work available at URL

2 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1398-9995.2003.00081.x

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1398-9995.2003.00081.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

3 January 2024

1 reference

2 August 2017

58

1 reference

2 August 2017

5

1 reference

2 August 2017

397-406

1 reference

Eosinophils in allergic reactions.

2 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Inhibitory effects of lodoxamide on eosinophil activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Inhibition of histamine release from human lung in vitro by antihistamines and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Eosinophil trafficking to sites of allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Gastrointestinal eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

IL-5-induced airway eosinophilia--the key to asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Elemental signals regulating eosinophil accumulation in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Effect of roxithromycin on eotaxin-primed reactive oxygen species from eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Chemokines in the limbal form of vernal keratoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Influence of IgE-mediated activation of cultured human mast cells on proliferation and type I collagen production by human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

A novel anti-allergic drug, betotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Major basic protein and topical administration of ketotifen in pollinosis under natural allergen provocation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00081.X

7 January 2021

Allergic eye disease mechanisms

1

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

The eosinophil and the eye.

3 January 2024

2

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Eosinophil granule major basic protein inhibition of corneal epithelial wound healing

3 January 2024

4

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation.

3 January 2024

9

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders

3 January 2024

12

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma

3 January 2024

13

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Inhibition of eosinophils degranulation by Ketotifen in a patient with milk allergy, manifested as bronchial asthma--an electron microscopic study

3 January 2024

20

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Effect of ketotifen and oxatomide on histamine secretion from mast cells

3 January 2024

23

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent

3 January 2024

24

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage

3 January 2024

31

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma

3 January 2024

33

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin

3 January 2024

40

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells

3 January 2024

41

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Effects of antiallergic drugs on histamine release from rat peritoneal mast cells induced by bradykinin

3 January 2024

42

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases

3 January 2024

44

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis

3 January 2024

52

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2003.00081.X

3 January 2024

Identifiers

1 reference

2 August 2017

1 reference